Western blotting and RT-PCR analysis confirmed that the degree of up-regulation of both ifi202 and survivin are greater in tumor-activated CTLs than in CD3 mAb-activated CTLs (Fig. 7A). The gene discussed is BIRC5; the disease is neoplasm.